Pralidoxime Chloride (pralidoxime chloride)

Organophosphate Poisoning Antidote Intramuscular Pen Injector (Ml)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

USES: This medication is used with atropine to treat nerve agent poisoning by certain chemicals known as anticholinesterase agents (such as organophosphate pesticides such as parathion, "nerve gas" such as sarin, other nerve agents such as VX). Pralidoxime works by restoring the activity of a certain natural substance (cholinesterase) needed by nerves and muscles. Symptoms of nerve agent poisoning may include trouble breathing, headache, runny nose, drooling, vision changes, sweating, abdominal cramps, nausea, vomiting, diarrhea, muscle twitching/jerking, drowsiness, confusion, and seizures.

Pralidoxime works mostly on the muscles (including breathing muscles) to decrease twitching, cramping, weakness, and paralysis. Another medication (atropine) is used to treat these and other symptoms of nerve agent poisoning such as slow/shallow breathing, wheezing, increased sweating/saliva, abdominal cramps, vomiting, and diarrhea.

Generic name: pralidoxime chloride
Pronunciation: (PRAL-i-DOX-eem)
Drug class: Organophosphate Poisoning Antidote
Therapeutic class: Antidotes and other Reversal Agents

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Pralidoxime Chloride

Intelligence content is not available yet.

Indications

The following indications are listed for Pralidoxime Chloride:

  • Cholinesterase Inhibitors Toxicity
  • Organophos Insecticide Poisoning
  • Organophosphorous Overdose
  • Poisoning Due To Nerve Agent

Also known as: Anticholinesterase Agent Poisoning, Organophosphate Poisoning, Poisoning By War Nerve Agent.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

CodeTypeDescription
Cholinesterase inhibitors toxicity
T44.0x1AICD10CMPoisoning by anticholinesterase agents, accidental (unintentional), initial encounter
T44.0x2AICD10CMPoisoning by anticholinesterase agents, intentional self-harm, initial encounter
T44.0x3AICD10CMPoisoning by anticholinesterase agents, assault, initial encounter
T44.0x4AICD10CMPoisoning by anticholinesterase agents, undetermined, initial encounter
Organophos insecticide poisoning
T60.0ICD10CMToxic effect of organophosphate and carbamate insecticides
T60.0xICD10CMToxic effect of organophosphate and carbamate insecticides
T60.0x1ICD10CMToxic effect of organophosphate and carbamate insecticides, accidental (unintentional)
T60.0x1AICD10CMToxic effect of organophosphate and carbamate insecticides, accidental (unintentional), initial encounter
T60.0x2ICD10CMToxic effect of organophosphate and carbamate insecticides, intentional self-harm
T60.0x2AICD10CMToxic effect of organophosphate and carbamate insecticides, intentional self-harm, initial encounter
T60.0x3ICD10CMToxic effect of organophosphate and carbamate insecticides, assault
T60.0x3AICD10CMToxic effect of organophosphate and carbamate insecticides, assault, initial encounter
T60.0x4ICD10CMToxic effect of organophosphate and carbamate insecticides, undetermined
T60.0x4AICD10CMToxic effect of organophosphate and carbamate insecticides, undetermined, initial encounter
Organophosphorous overdose
T44.0x1AICD10CMPoisoning by anticholinesterase agents, accidental (unintentional), initial encounter
T44.0x2AICD10CMPoisoning by anticholinesterase agents, intentional self-harm, initial encounter
T44.0x3AICD10CMPoisoning by anticholinesterase agents, assault, initial encounter
T44.0x4AICD10CMPoisoning by anticholinesterase agents, undetermined, initial encounter

ICD code information from First Databank (FDB).

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data